J Biol Chem, Vol. 274, Issue 35, 25136-25143, August 27, 1999
Enzymatic Repair of 5-Formyluracil
I. EXCISION OF 5-FORMYLURACIL SITE-SPECIFICALLY INCORPORATED
INTO OLIGONUCLEOTIDE SUBSTRATES BY AlkA PROTEIN (Escherichia
coli 3-METHYLADENINE DNA GLYCOSYLASE II)*
Aya
Masaoka,
Hiroaki
Terato,
Mutsumi
Kobayashi,
Akiko
Honsho,
Yoshihiko
Ohyama, and
Hiroshi
Ide
From the Graduate Department of Gene Science, Faculty of Science,
Hiroshima University, Kagamiyama,
Higashi-Hiroshima 739-8526, Japan
 |
ABSTRACT |
5-Formyluracil (fU) is a major thymine lesion
produced by reactive oxygen radicals and photosensitized oxidation. We
have previously shown that fU is a potentially mutagenic lesion due to
its elevated frequency to mispair with guanine. Therefore, fU can exist
in DNA as a correctly paired fU:A form or an incorrectly paired fU:G
form. In this work, fU was site-specifically incorporated opposite A in
oligonucleotide substrates to delineate the cellular repair mechanism
of fU paired with A. The repair activity for fU was induced in
Escherichia coli upon exposure to
N-methyl-N'-nitro-N-nitrosoguanidine, and the induction was dependent on the alkA gene,
suggesting that AlkA (3-methyladenine DNA glycosylase II) was
responsible for the observed activity. Activity assay and determination
of kinetic parameters using purified AlkA and defined oligonucleotide
substrates containing fU, 5-hydroxymethyluracil (hU), or
7-methylguanine (7mG) revealed that fU was recognized by AlkA with an
efficiency comparable to that of 7mG, a good substrate for AlkA,
whereas hU, another major thymine methyl oxidation products, was not a substrate. 1H and 13C NMR chemical shifts of
5-formyl-2'-deoxyuridine indicated that the 5-formyl group caused base
C-6 and sugar C-1' to be electron deficient, which was shown to result
in destabilization of the N-glycosidic bond. These features
are common in other good substrates for AlkA and are suggested to play
key roles in the differential recognition of fU, hU, and intact
thymine. Three mammalian repair enzymes for alkylated and oxidized
bases cloned so far (MPG, Nth1, and OGG1) did not recognize fU,
implying that the mammalian repair activity for fU resided on a yet
unidentified protein. In the accompanying paper (Terato, H., Masaoka,
A., Kobayashi, M., Fukushima, S., Ohyama, Y., Yoshida, M., and Ide, H.,
J. Biol. Chem. 274, 25144-25150), possible repair
mechanisms for fU mispaired with G are reported.
 |
INTRODUCTION |
Cellular DNA is constantly subjected to the threat of exogenous
and endogenous DNA damaging agents (1, 2). The loss of critical genetic
information stored in DNA due to the damage results in lethal and
mutagenic events of cells. Furthermore, it has been shown that
defective processing of DNA damage, i.e. impaired DNA repair
and cellular responses to DNA damage, lead to tumorigenesis and
carcinogenesis (1). Reactive oxygen species generated by cellular
metabolism, exogenous redox active chemicals, and ionizing radiation
produce a wide spectrum of oxidative DNA base damage, which constitutes
major DNA lesions induced by exogenous and endogenous DNA damaging
agents (3, 4). To cope with genotoxicity associated with oxidative base
damage, cells have evolved a number of repair enzymes that specifically
recognize unique structural features of altered bases and remove them
from DNA (1, 2, 5). Among the repair enzymes that recognize oxidative
base damage from four bases, those for thymine damage have been best
identified and characterized, because the chemical nature of oxidative
thymine damage has been established considerably well (3, 4). Oxidative
thymine lesions are classified into four groups depending on the
structure: group I, C-5,C-6 hydroxylation products, such as thymine
glycol and thymine hydrate; group II, ring fragmentation products, such
as urea and methyltartronylurea; group III, ring contraction products,
such as hydantoin derivatives; and group IV, 5-methyl oxidation
products, such as 5-formyluracil (fU)1 and
5-hydroxymethyluracil (hU). In Escherichia coli, group I products are recognized by endonucleases III and VIII (6-10), encoded
by the nth (11, 12) and nei (13, 14) genes,
respectively. Recently, eukaryotic counterparts of the nth
gene have been cloned, and the expressed gene products were shown to
have activities similar to the E. coli enzyme (15-18).
Group II lesions, such as urea residues, are recognized by a number of
E. coli apurinic/apyrimidinic endonucleases without
(exonuclease III and endonuclease IV) (19-21) and with associated
N-glycosylase activities (endonucleases III and VIII,
formamidopyrimidine DNA glycosylase) (7, 8, 10, 21, 22). Similar to
E. coli endonuclease III, eukaryotic endonuclease III
homologues appear to recognize urea type products, as well as group I
products (15, 16, 18). However, somewhat surprisingly, bovine
apurinic/apyrimidinic endonuclease 1 does not recognize urea residues
(23), despite sharing considerable amino acid sequence homology with
E. coli exonuclease III (24). Repair enzymes for group III
and IV products have been much less clarified compared with those for
group I and II products. Available data indicate that
5-hydroxy-5-methylhydantoin, a group III product, is a substrate of
E. coli endonuclease III (8, 9, 25). Concerning the repair
of the group IV products, mammalian cells contain an activity that
releases hU from DNA (26, 27). However, hU itself is neither a lethal
nor mutagenic lesion (28). Thus, further characterization of the
activity and elucidation of the physiological role remain to be performed.
We have recently shown that fU belonging to group IV products forms a
mispair with guanine in addition to a correct base pair with adenine
during DNA replication (29). Ionization of fU promoted by the
electron-withdrawing formyl group is involved in the mispairing between
fU and guanine. It has been also demonstrated that the nucleoside and
nucleotide forms of fU undergo specific modification by cysteine
derivatives, although the biological relevance of this modification
remains to be elucidated (30). In addition, exogenous
5-formyl-2'-deoxyuridine added to the culture medium exhibits the
mutagenic effect on Salmonella TA102 and human cells (31,
32). Thus, in light of such genotoxic and cytotoxic potentials of fU,
this lesion should be subjected to repair in cells. Previously, Bjelland et al. (33) found that fU was released from aged
and photo-oxidized DNA by E. coli AlkA protein
(3-methyladenine DNA glycosylase II) during a survey of the substrate
specificity of the enzyme. Subsequently, it was reported that the
activity that release fU from damaged DNA was present in crude extracts
of mammalian cells (32, 34).
In the present work and the accompanying report (68), we prepared
oligonucleotide substrates containing fU as unique damage and studied
the repair of fU to obtain further insight into the cellular repair
mechanism. The use of defined oligonucleotide substrates, which was not
achieved in the previous studies, is essential to compare the substrate
specificity and kinetic parameters of repair enzymes. More importantly,
fU could be present in two different base pairs in DNA, i.e.
a correctly paired fU:A form and a mispaired fU:G form. We report here
that fU paired with A is specifically removed by E. coli
AlkA protein with an efficiency comparable to that of 7-methylguanine
(this paper). Furthermore, an fU:G mismatch generated during DNA
replication is likely to be subjected to repair by both AlkA protein
and the MutHLS mismatch correction system (68).
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
7-Methyl-2'-dGTP was purchased from Sigma. Four
normal dNTPs were obtained from Amersham Pharmacia Biotech, and
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was from Wako. Preparation of 5-formyl-2'-deoxyuridine 5'-triphosphate (fdUTP) was reported previously (29).
5-Hydroxymethyl-2'-deoxyuridine 5'-triphosphate (hdUTP) was synthesized
by NaBH4 reduction of fdUTP and extensively purified by
HPLC as described for fdUTP (29). The structure and purity of hdUTP
were confirmed by alkaline phosphatase digestion of the triphosphate to
the corresponding nucleoside followed by reversed phase HPLC analysis
(data not shown). 3',5'-Di-O-accetylthymidine and
3',5'-di-O-acetyl-5-formyl-2'-deoxyuridine were synthesized
according to the reported methods (35).
Bacteria--
E. coli MV1161 (thr1, ara14,
leuB6, DEL(gpt-proA)62, lacY1, tsx33, supE44, galK2, hisG4, rfbD1,
mgl51, rpsL31, kdgK51, xyl5, mtl1, argE3, thi1, rfa550) and MV1571
(alkA51::Mudl(AmpRlac) in
MV1161) were gifts from Humayun and Dunman (New Jersey Medical School)
(36) and were originally from Volkert et al. (37). E. coli JM105 (endA1, supE, sbcB15, thi, rpsL,
(lac-proAB)/F'(traD36, proAB+,
lacIq, lacZ
M15)) was purchased from
Amersham Pharmacia Biotech.
Buffer--
The following buffers were used for enzyme
reactions: Buffer A for Pol I Klenow fragment, 66 mM
Tris-HCl (pH 7.5), 1.5 mM 2-mercaptoethanol, 6.6 mM MgCl2; Buffer B for AlkA, 70 mM
Hepes-KOH (pH 7.8), 1 mM EDTA, 5 mM
2-mercaptoethanol; Buffer C for hMPG, 35 mM Hepes-KOH (pH
7.4), 50 mM NaCl, 5 mM EDTA, 5 mM
dithiothreitol; Buffer D for mNth1, 20 mM Hepes-KOH (pH
8.0), 50 mM KCl, 0.25 mM EDTA, 0.25 mM dithiothreitol, 0.1 mg/ml bovine serum albumin; Buffer E
for endonuclease IV, 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA; and Buffer F for hOGG1, 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 2 mM EDTA, 0.1 mg/ml bovine serum albumin. Gel loading buffer
consisted of 0.05% xylene cyanol, 0.05% bromphenol blue, 20 mM EDTA, and 98% formamide.
Enzymes--
E. coli DNA polymerase I Klenow fragment
and T4 polynucleotide kinase were purchased from Life Technologies,
Inc. and New England BioLabs, respectively. E. coli
endonuclease IV was a gift from Hatahet and Wallace (University of
Vermont). Human methylpurine DNA glycosylase (hMPG/Anpg) and
7,8-dihydro-8-oxoguanine DNA glycosylase (hOGG1/hMMH, splicing isoform
1a) were obtained from Kubo (38) and Nishimura (39), respectively. The
mouse endonuclease III homologue (mNth1) was purified from E. coli NKJ1004 (nth
nei
)
harboring plasmid PEK/mNth1 (18).
3-Methyladenine DNA glycosylase II (AlkA protein) was purified as
follows. Based on the published sequence data (40), the alkA
gene containing upstream 2 and downstream 57 extra nucleotides from the
start and stop codons, respectively, was amplified by PCR from E. coli K12 genomic DNA using primers PCR-FW and PCR-RV (Table
I). The amplified gene (approximately 1 kilobase) was restricted by EcoRI and HindIII,
and inserted into the EcoRI/HindIII site of
pKK223-3 (Amersham Pharmacia Biotech). The plasmid containing the
alkA gene was designated pAlkA. The whole nucleotide
sequence of the inserted alkA gene was confirmed by DNA
sequencing. E. coli JM105 transformed with pAlkA was grown
in LB medium (5 l) supplemented with 50 µg/ml ampicillin at 37 °C
in a jar fermenter, and the alkA gene was induced by the
addition IPTG (0.4 mM) at an absorbance of 0.2. Incubation
was continued for further 9 h at 37 °C with aeration. Cells
were collected by centrifugation, washed with 40 mM
Tris-HCl (pH 8.0), and disrupted by the lysozyme treatment and repeated
freeze-thaw cycles. Crude AlkA protein was precipitated by ammonium
sulfate (45% saturation) and purified by the successive chromatography
using HiLoad Superdex 75 pg, Resource S, and Resource Q columns (all
columns were from Amersham Pharmacia Biotech) following the reported
procedure (33). Ten N-terminal amino acid residues of the purified
protein were determined by a protein sequencer and were consistent with
those expected from the DNA sequence. The AlkA protein concentration
after the Resource Q column was determined by UV absorption assuming
280 = 59,400,2
and used for enzyme assays.
Oligonucleotides--
Oligonucleotides used in this study are
listed in Table I. Oligonucleotides except 25T, 25FU, 25HU, 25MG, 25FP,
19TG, and M1 were synthesized by the standard phosphoramidite method
and purified by reversed phase HPLC. 25FU and 25HU containing fU and hU, respectively, at the 16th position from the 5'-terminus were prepared by the enzymatic extension of primer P1. Typically, P1 was
5'-end labeled with [
-32P]ATP (110 TBq/mmol, Amersham
Pharmacia Biotech) and T4 polynucleotide kinase and purified as
described (41). P1 annealed to the template 30A (12.5 pmol as a
template/primer) in Buffer A (total volume, 500 µl) was extended by
E. coli DNA polymerase I Klenow fragment (90 units) with
fdUTP (100 µM) or hdUTP (100 µM) at
37 °C for 5 min and then with additional dATP, dGTP, and dCTP (100 µM each) for 30 min (29). The reaction was terminated by
the addition of EDTA (final concentration, 25 mM). The
reaction mixture was extracted with phenol, and duplex 25FU/30A and
25HU/30A were precipitated by ethanol. They were resuspended in water
(100 µl), purified by Sephadex G-25 chromatography (bed volume, 2 ml), and recovered by ethanol precipitation. Duplex 25T/30A was
prepared by the same procedure except that dTTP was used instead of
fdUTP in the DNA polymerase reaction. It is noted that fully replicated
products 25FU and 25T were 25-mer in length. This design aided
separation of these oligonucleotides from longer template 30A by
polyacrylamide gel electrophoresis when single stranded 25FU and 25T
were needed to construct heteroduplex substrates in MutS binding
experiments described in the accompanying paper (68). Duplex 25MG/30C
containing 7-methylguanine (7mG) was prepared and purified in a manner
essentially similar to that described for 25FU/30A. 5'-Labeled P2 was
annealed to the template 30C and elongated in the presence of dCTP,
dTTP, 7-methyl-2'-dGTP (100 µM each). 7mG incorporated
into 25MG was stable when stored at 4 °C or below so that no
detectable sites sensitive to endonuclease IV (abasic sites) or
formamidopyrimidine DNA glycosylase
(2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine (Fapy))
were generated during the storage. Duplex 25FP/30C containing Fapy was
prepared by alkali treatment of 25MG/30C. The details of the synthesis
and characterization of the oligonucleotides containing 7mG and Fapy
will be published elsewhere.3
19TG containing a thymine glycol was prepared by KMnO4
oxidation of the oligonucleotide containing a single thymine at the
same position and was extensively purified by reversed phase HPLC (42). The marker oligonucleotide M1 was prepared by the treatment of 19TG
with 10% piperidine at 90 °C for 30 min.
Enzyme Assay with Crude Cell Extracts--
To analyze induction
of repair activities by MNNG, E. coli MV1161
(alkA+) and MV1571
(alkA
) were treated with MNNG as reported
previously (43). E. coli MV1161 and MV1571 were grown
overnight in LB medium in the absence (MV1161) and presence (MV1571) of
50 µg/ml ampicillin. The overnight cultures were inoculated into the
same fresh medium with 8-fold dilution. After 3 h of incubation at
37 °C with shaking, MNNG was added to the medium at a final
concentration of 20 µM, and incubation was continued for
1.5 h at 37 °C. Cells were collected by centrifugation, and
0.2 g of wet cells was treated by 1 mg/ml lysozyme in 10 mM Tris-HCl (pH 8.0), 5 mM EDTA (total volume, 0.5 ml) and then subjected to repeated freeze-thaw cycles three times.
Cell debris were removed by centrifugation, and the protein concentration of the supernatant was determined by the BCA protein assay reagent kit (Pierce). Repair activities for fU and 7mG in the
crude cell extracts were assayed as follows. 5'-End labeled oligonucleotide substrates (25FU/30A and 25MG/30C, 20 nM)
were incubated with 20 µg of crude cell extracts in Buffer B (50 µl) at 37 °C for 30 min. The reaction mixtures was extracted by
phenol. Oligonucleotides were precipitated by ethanol and resuspended in Buffer E (10 µl). Endonuclease IV (4 ng) was added to the reaction mixture, and incubation was continued at 37 °C for 30 min. The reaction was terminated by adding gel loading buffer. Samples were
subjected to polyacrylamide gel electrophoresis (PAGE) analysis.
The repair activity for fU in crude cell extract from E. coli JM105 harboring pAlkA or pKK223-3 (control) was assayed as
follows. E. coli JM105 harboring pAlkA or pKK223-3 was grown
in LB medium containing 50 µg/ml ampicillin at 37 °C overnight.
The overnight culture was inoculated in fresh LB medium containing 50 µg/ml ampicillin with 16-fold dilution. After 3 h of incubation
at 37 °C, IPTG was added to the medium at a final concentration 0.4 mM. Cells were collected at appropriate incubation times
and stored frozen at
80 °C. Cell extracts were prepared, and the
repair activity was assayed using substrates 25FU/30A and 25MG/30C, as described for the MNNG treatment.
Enzyme Assay with Purified Enzymes--
Oligonucleotide
substrates, such as 25FU/30A and 25MG/30C (typically 20 nM), were incubated with AlkA protein (10 ng) in Buffer B
(10 µl) at 37 °C for 10 min unless otherwise noted. After
incubation, DNA was purified by phenol extraction and ethanol
precipitation. The purified DNA was incubated with endonuclease IV (4 ng) at 37 °C for 30 min in Buffer E (10 µl), mixed with gel
loading buffer, and finally subjected to gel electrophoresis. Kinetic
parameters of AlkA for fU and 7mG were determined in an essentially
similar manner using substrates 25FU/30A and 25MG/30C with a
concentration range of 5-100 nM.
Reactions with mammalian enzymes were performed as follows. 19TG and
25OG were 5'-end labeled and purified as described above and annealed
to the complementary strands 19A and 30C, respectively. 19TG/19A and
25FU/30A (20 nM) were incubated with mNth1 (1-10 ng) in
Buffer D (10 µl) at 37 °C for 30 min. 25OG/30C, 25FP/30C, and
25FU/30A (20 nM) were also treated in a similar manner by hOGG1(60 ng) in Buffer F (10 µl). 25MG/30C and 25FU/30A (20 nM) were incubated with hMPG (5-50 ng) in Buffer C (10 µl) at 37 °C for 30 min. For hMPG, DNA was purified and further
treated with endonuclease IV as described for AlkA.
Electrophoresis and Autoradiography--
After adjusting total
radioactivity, samples in gel loading buffer were loaded onto a 16%
denaturing polyacrylamide gel and electrophoresed at 2000 V for 2-3 h.
The gel was autoradiographed at
80 °C. The radioactivity of
separated bands was quantitated by Fuji BAS 2000.
NMR Spectra--
1H and 13C NMR spectra
of 3',5'-diacetyl derivatives of thymidine and 5-formyl-2'-deoxyuridine
were measured in CDCl3 on a Varian Gemini 200 spectrometer
at 200 (1H) and 50.3 (13C) MHz, respectively,
with tetramethylsilane (1H) and the solvent signal
(13C) as internal standards.
 |
RESULTS |
Parallel Induction of Repair Activities for fU and 7mG by MNNG
Treatment of E. coli Cells--
E. coliMV1161
(alkA+) and MV1571
(alkA
) were treated with a sublethal dose
of MNNG, and induction of the repair activity for fU and 7mG in cells
was examined using substrates containing these damage (25FU/30A and
25MG/30C). The substrates incubated with crude cell extracts were
further treated with endonuclease IV to cleave abasic sites potentially
formed in the substrates. Fig. 1 shows
the results of product analysis by PAGE, where bands of original
substrates (25FU and 25MG) and reaction products resulting from
specific cleavage at fU or 7mG site are indicated by arrows. In MV1161 cells (alkA+), repair activity for fU
was in a basal level and was not clearly seen over the background
before the MNNG treatment (Fig. 1, lane 10), but it was
noticeably induced after the treatment (lane 11). In
contrast, such induction did not occur in the
alkA
mutant MV1571 (lanes 12 and
13). The induction pattern of the repair activity for fU was
identical to that of 7mG so that a clear band indicating the repair of
7mG appeared over the background only in MNNG-treated wild type cells
(MV1161, lane 5), but not in the
alkA
mutant (lane 7). These results
suggest that the repair activity for fU are inducible by MNNG in
E. coli and is probably associated with AlkA protein.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
MNNG induction of the repair activities for
fU and 7mG in E. coli cells. E. coli
MV1161 (alkA+) and MV1571
(alkA ) were treated with or without 20 µM MNNG at 37 °C for 1.5 h, and cell extracts
were prepared by the freeze-thaw method. 25FU/30A containing fU and 25 MG/30C containing 7mG (both at 20 nM) were incubated with
the cell extracts (20 µg as protein) in Buffer B (50 µl) at
37 °C for 10 min. After incubation, oligonucleotides were purified
by phenol extraction followed by ethanol precipitation, and treated
with endonuclease IV (4 ng) in Buffer E (10 µl) at 37 °C for 30 min. Reaction products were analyzed by 16% PAGE. Lane 1, marker oligonucleotide P1 (see Table I); lane 2, untreated
25MG/30C; lane 3, 25MG/30C incubated with endonuclease IV
alone; lanes 4 and 5, 25MG/30C incubated with the
extract from alkA+ cells treated without ( ) or
with (+) MNNG; lanes 6 and 7, 25MG/30C incubated
with the extract from alkA cells treated
without ( ) or with (+) MNNG; lane 8, untreated 25FU/30A;
lane 9, 25FU/30A incubated with endonuclease IV alone;
lanes 10 and 11, 25FU/30A incubated with the
extract from alkA+ cells treated without ( )
and with (+) MNNG; lanes 12 and 13, 25FU/30A
incubated with the extract from alkA cells
treated without ( ) and with (+) MNNG.
|
|
Recognition of fU by AlkA--
Because it was suggested by the
MNNG induction experiments that AlkA had an repair capacity for fU as
well as 7mG, the cloned alkA gene was overexpressed in
E. coli, and the repair activity was examined using crude
cell extracts and purified protein. As shown in Fig.
2, significant repair activities for both
fU and 7mG were present in cell extracts prepared from IPTG-induced
JM105 harboring pAlkA (lanes 5 and 9), but not
pKK223-3, a control parental vector (lanes 4 and
8).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Overexpression of repair activities for fU
and 7mG in E. coli harboring pAlkA. Cell extracts
were prepared from JM105 harboring pKK223-3 (parental vector) or pAlkA
containing the alkA gene after IPTG induction. 25MG/30C
containing 7mG and 25FU/30A containing fU (both 20 nM) were
incubated without or with the cell extracts and treated with
endonuclease IV as described in Fig. 1. Lane 1, marker
oligonucleotide P1 (Table I); lane 2, untreated 25MG/30C;
lane 3, 25MG/30C incubated with endonuclease IV alone;
lanes 4 and 5, 25MG/30C incubated with the
extracts from JM105/pKK223-3 (indicated as pKK223) and JM105/pAlkA
(indicated as pAlkA), respectively; lanes 6-9, the same as
lanes 2-5 but the substrate was 25FU/30C.
|
|
AlkA protein was overproduced in JM105/pAlkA and purified by successive
chromatography as described under "Experimental Procedures." Purified AlkA protein was physically homogenous and gave a single band
with an apparent molecular mass of 30 kDa in SDS-PAGE (Fig. 3). Purified AlkA exhibited repair
activity for both fU and 7mG (Fig. 4).
The activity for the both damage increased in a parallel manner with
the amount of AlkA protein added to the reaction, indicating that the
activity for fU and 7mG resided on the same protein AlkA. Furthermore,
comparison of the amounts of reaction products for fU and 7mG suggests
that both damages are recognized by AlkA with a similar efficiency.

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 3.
SDS-PAGE analysis of the purified fractions
of AlkA. Protein was separated by 10% SDS-PAGE and visualized by
silver staining. Lane 1, molecular weight markers;
lane 2, cell extract from JM105/pAlkA (1 µg); lane
3, 45% ammonium sulfate precipitation (1 µg); lane
4, HiLoad Superdex 75 pg (0.2 µg); lane 5, Resource S
(0.1 µg); lane 6, Resource Q (0.1 µg). The amount of
protein loaded in each lane is indicated in the parentheses.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Repair activity of purified AlkA for fU and
7mG. 25FU/30A and 25MG/30C (both 20 nM) were incubated
with varying amounts of purified AlkA (Resource Q fraction) in Buffer B
(10 µl) at 37 °C for 10 min. After incubation, oligonucleotides
were purified by phenol extraction followed by ethanol precipitation,
and treated with endonuclease IV (4 ng) in Buffer E (10 µl) at
37 °C for 30 min. Reaction products were analyzed by 16% PAGE.
Lane 1, untreated 25FU/30A; lanes 2-5, 25FU/30A
treated with increasing amounts of AlkA (1, 4, 11, and 107 ng,
respectively); lane 6, untreated 25 MG/30C; lanes
7-10, 25MG/30C treated with increasing amounts of AlkA (1, 4, 11, and 107 ng, respectively).
|
|
Kinetic Parameters for Recognition of fU and 7mG--
To compare
the reaction efficiencies of AlkA for fU and 7mG, the initial reaction
velocity was determined using 25FU/30A and 25MG/30C with a substrate
concentration range of 5-100 nM. Fig. 5 shows the substrate-velocity plots for
fU and 7mG. The kinetic parameters (Km and
Vmax) were evaluated using a hyperbolic curve
fitting program and are summarized in Table
II. The data are averages of four
independent experiments. Judging from Km for fU (21 nM) and 7mG (30 nM), the apparent affinity of
AlkA for fU was slightly higher than that for 7mG, whereas
Vmax values for fU and 7mG were essentially
comparable. The ratio of the overall reaction efficiencies
(Vmax/Km) for 7mG
versus fU was 1:1.4, showing that fU and 7mG were equally
good substrates for AlkA.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Substrate-velocity plots for the
excision of fU and 7mG by AlkA. 25FU/30A and 25MG/30C were
incubated with AlkA (10 ng) in Buffer B (10 µl) at 37 °C for 10 min and treated with endonuclease IV as described in Fig. 4. After gel
electrophoretic separation, the radioactivity of substrates and nicked
products in the gel were quantitated by BAS 2000. The initial velocity
(V) was obtained with varying substrate concentrations
(S) (5-100 nM). A, fU; B,
7mG. Mean values of four independent experiments are plotted;
error bars show S.D.
|
|
Activity of AlkA to hU--
Reactive oxygen radicals generate two
major stable methyl oxidation products of thymine, i.e. fU
and hU (3, 31). To elucidate whether or not AlkA recognized hU, this
damage was introduced into the same site as fU in the oligonucleotide
25HU. Duplex substrates 25HU/30A as well as 25T/30A and 25FU/30A were
incubated with AlkA, and reaction products were analyzed by PAGE (Fig.
6). Although AlkA acted on fU very
efficiently (lanes 7 and 9) under these conditions, hU introduced into the same site was not recognized (lanes 11 and 13). Similarly, intact thymine was
not a substrate of AlkA either (lanes 3 and 5).
Thus, AlkA differentially recognizes the effects of modifications in
the 5-substituent group.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Differential activities of AlkA for T, fU,
and hU. 25T/30A, 25FU/30A, and 25HU/30A (2 or 20 nM)
containing T, fU, and hU, respectively, at the same position were
incubated with AlkA (50 ng) in Buffer B (10 µl) at 37 °C for 20 min and then treated with endonuclease IV as described in Fig. 4. After
adjusting radioactivity, reaction products were separated by 16% PAGE.
Lane 1, marker oligonucleotide P1 (Table I). For lanes
2-13, substrates, their concentrations, and treatment without
( ) or with (+) AlkA are indicated on the top of the lanes.
|
|
Activity of Mammalian Repair Enzymes to fU--
Mammalian cells
have functional homologues of AlkA that exhibit a substrate specificity
similar to AlkA (44-48). In addition, they have endonuclease III
(16-18) and MutM (39, 49-52) homologues that recognize oxidized
pyrimidine and purine bases, respectively. Three mammalian homologues,
cloned human methylpurine DNA glycosylase (hMPG/Anpg) (46-48), mouse
endonuclease III homologue (mNth1) (18), and human MutM homologue
(hOGG1/hMMH) (39, 49-52), were tested for fU to ask whether fU was
recognized by these enzymes. The enzymes were incubated with 25FU/30A
and other control substrates (25MG/30C, 19TG/19A, 25OG/30C, and
25FP/30C), and products were analyzed by PAGE (Fig.
7). Although the tested enzymes
recognized their canonical substrates (7mG (Fig. 7A, lane
14), thymine glycol (Fig. 7A, lane 16),
7,8-dihydro-8-oxoguanine (Fig. 7B, lane 3), and Fapy (Fig.
7B, lane 5), respectively), none of them
recognized fU. Thus, no cleavage product appeared in the gel (Fig.
7A, lanes 6-11, and Fig. 7B, lane 7).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
PAGE analysis of the repair activities of
AlkA, mNth1, hMPG, and hOGG1 for fU and other lesions.
A, 25FU/30A, 25MG/30C, and 19TG/19A (all 20 nM)
were treated with AlkA, mNth1, or hMPG at 37 °C for 10 min (AlkA) or
30 min (mNth1 and hMPG). For AlkA and hMPG, reaction products were
further treated with endonuclease IV as described in Fig. 4. Lane
1, marker oligonucleotide P1 (Table I); lane 2, untreated 25FU/30A; lanes 3-11, 25FU/30A treated with
increasing amounts of AlkA (1, 5, 10 ng), mNth1 (1, 5, 10 ng), and hMPG
(5, 25, 50 ng); lane 12, marker oligonucleotide P2 (Table
I); lane 13, untreated 25MG/30C; lane 14, 25MG/30C treated with hMPG (50 ng); lane 15, untreated
19TG/19A; lane 16, 19TG/19A treated with mNth1 (10 ng);
lane 17, marker oligonucleotide M1 prepared by hot
piperidine treatment of 19TG (Table I). The -elimination product
formed by mNth1 (lane 16) migrated more slowly than the
-elimination product (M1) formed by the piperidine treatment
(lane 17). B, 25OG/30C, 25FP/30C, and 25FU/30A
(all 20 nM) were treated with hOGG1 (60 ng) at 37 °C for
30 min. Lane 1, marker oligonucleotide P2; lanes
2 and 3, 25OG/30C without ( ) and with (+) hOGG1
treatment; lanes 4 and 5, 25FP/30C without and
with hOGG1 treatment; lanes 6 and 7, 25FU/30C
without and with hOGG1 treatment. The mobility of the reaction product
from 25OG and 25FP (lanes 3 and 5) was slightly
lower than that of P2 (lane 1) because hOGG1 generated
strand breaks by the -elimination mechanism (38, 48-51).
|
|
NMR Spectra of 3',5'-di-O-acetyl-5-formyl-2'-deoxyuridine--
To
obtain chemical insight into the substrate recognition and catalytic
mechanisms of AlkA, 1H and 13C NMR spectra of
5-formyl-2'-deoxyuridine and thymidine (as 3',5'-di-O-acetyl derivatives) were measured, and their chemical shifts were compared (Table III). Oxidation of the 5-methyl
group in thymidine to the formyl group resulted in significant
down-field shifts of H6 (
= 1.22 ppm) and C6 (
= 12.1 ppm) signals along with those of the formyl group itself. These shifts
clearly indicate that the influence of the electron-withdrawing formyl
group is extended to the pyrimidine ring via the
electron system,
making H6 and C6 atoms electron-deficient relative to thymidine. The
formyl group also caused deoxyribose C-1' to be somewhat
electron-deficient, as judged from the noticeable down-field shift of
the 13C signal of this atom (
= 6.1 ppm).
View this table:
[in this window]
[in a new window]
|
Table III
1H and 13C NMR chemical shifts of 3',5'-di-O-acetyl
derivatives of 5-formyl-2'-deoxyuridine (fdU) and thymidine (dT)
|
|
 |
DISCUSSION |
E. coli has two DNA glycosylases for alkylated bases,
Tag (3-methyladenine DNA glycosylase I) and AlkA (3-methyladenine DNA glycosylase II) (53). Both enzymes are monofunctional DNA glycosylases without any associated endonuclease or apurinic/apyrimidinic lyase activity. Tag is constitutively expressed in cells and acts only on
3-methyladenine (3mA), whereas AlkA is inducible upon exposure to
alkylating agents (40, 54) and excises structurally diverse damaged
bases, such as 3mA, 7mG, O2-methylcytosine,
O2-methylthymine, etc. (55, 56). Functional
homologues of AlkA have been cloned from several eukaryotic sources
(44-48). In this work, we have unambiguously demonstrated that AlkA
recognizes fU, a major oxidation product of thymine, using a defined
oligonucleotide substrate. This conclusion is supported by several
lines of evidence: (i) induction of the repair activity in response to
the MNNG treatment, and its absence in the alkA mutant (Fig.
1), (ii) increased repair activity in the cell extract of E. coli harboring pAlkA (Fig. 2), (iii) activity of purified AlkA to
fU (Fig. 4), and (iv) parallel observation of the above results
(i-iii) for the substrates containing fU and 7mG. Similar to other
known substrates, AlkA acted as a simple DNA glycosylase on fU leaving
an abasic site because the nicked product of 25FU/30A was detected only
after the treatment with endonuclease IV (data not shown).
The activity of AlkA for fU demonstrated in the present study is
qualitatively consistent with the result reported by Bjelland et
al. (33), who showed the release of 3H-labeled fU from
aged or photo-oxidized DNA by AlkA. However, Km for
fU in their report varies dramatically depending on the substrates:
Km = 4.4 nM (aged DNA in a native state), 0.14 nM (aged DNA in a denatured state), and 116 nM (photo-oxidized DNA in a denatured state). Therefore, it
is rather confusing that the Km for native DNA,
supposed to be a better substrate, is higher than that for denatured
DNA, and Km values differ by 103-fold
between aged and photo-oxidized DNA. These results could arise from the
nature of the substrates. Both emission of
particles during the
aging of 3H-labeled DNA and photo-oxidation of DNA generate
multiple DNA lesions that may specifically or nonspecifically interact
with AlkA. Similarly, kinetic parameters of AlkA and its functional homologues for methylated bases have been determined using DNA substrates prepared by the treatment with methylating agents (33, 43,
53, 57, 58), which generate N- and O-methylated
purines and pyrimidines, methylphosphates, and abasic sites
simultaneously (59). Accordingly, parameters obtained from these
substrates tacitly contains the contributions from unintended lesions.
In contrast, the parameters determined in this study (Table II) reflect intrinsic values and can be directly compared with a reasonable basis
because the substrate contains a single fU or 7mG site as a unique
lesion. The kinetic parameters for fU and 7mG indicate that fU is a
comparable substrate with 7mG, known as a good substrate for AlkA. To
our knowledge, this is the first report of kinetic parameters of AlkA
for recognition of fU and 7mG site-specifically introduced into
oligonucleotide substrates. AlkA excises 3mA more rapidly than 7mG
despite the 3-8-fold abundance of 7mG over 3mA in alkylated DNA (59).
In addition, hypoxanthine (Hx) and
1,N6-ethenoadenine (
A) are extremely poor
substrates (58). Combining the published and present data, the rank of
damage as a substrate for AlkA is likely to be following: 3mA > fU ~ 7mG
Hx,
A > (hU). It is noteworthy that
apparent affinity (Km) of AlkA to these substrates
also decreases in this order: 3mA (7 nM), fU (21 nM), 7mG (30 nM), Hx (420 nM),
A
(800 nM) (Refs. 42 and 57 and this work).
Km for hU estimated using SPO1 phage DNA containing
3H-labeled hU is approximately 4000 nM,
indicating that hU is an extremely poor substrate (33). This is
essentially consistent with the present result that hU incorporated in
place for fU was not recognized by AlkA, because such a low activity,
even if present, was well below the detection limit of the present
experiment. The activity to hU observed in a previous work (33) might
be due to the recently reported unique activity of AlkA that releases normal bases from intact DNA (60).
Mammalian cells contain activities that release fU from oxidized DNA
(32, 34). Thus, we have tested three cloned mammalian repair enzymes,
hMPG/Anpg, mNth1, and hOGG1/hMMH, for fU. hMPG/Anpg is a human
N-alkylpurine glycosylase and has a certain overlapping substrate specificity with AlkA (55, 56), yet their genes show little
sequence homology (46-48). mNth1 is a mouse homologue of endonuclease
III, a major E. coli enzyme for oxidized pyrimidines (18).
mNth1 and endonuclease III share common features, such as the
helix-hairpin-helix motif, the 4Fe-4S cluster, and the amino acids
(Lys-208 and Asp-227 in mNth1) essential for the catalytic activity.
hOGG1/hMMH is a human functional homologue of E. coli MutM
(Fpg) that is responsible for the repair of oxidized purines, such as
7,8-dihydro-8-oxoguanine and Fapy (39, 49-51). These three enzymes
represent base excision repair enzymes for methylated and oxidized base
damage thus far cloned from mammalian cells. However, MPG/Anpg, mNth1,
and hOGG1/hMMH did not act on fU, although they recognized the
canonical substrates under the same conditions (Fig. 7), indicating
that the mammalian repair activity for fU so far reported is associated
with a yet unidentified protein.
Expression of the hMPG gene in E. coli alkA mutants corrects
the sensitivity to alkylating agents, suggesting that AlkA and hMPG
have a common function in removing lethal alkylated damage, such as 3mA
(46-48). However, precise modes of substrate recognition and cleavage
of the N-glycosidic bond are likely different. For example,
hMPG efficiently recognizes Hx and
A, which bear no positive charge
and are extremely poor substrates for AlkA (43, 58), whereas this
enzyme does not remove fU, a good substrate for AlkA (this work). These
differences might reflect the divergence of recognition and catalytic
mechanisms probably resulting from the lack of amino acid homology
between AlkA and hMPG.
Molecular basis of the substrate specificity of AlkA accepting diverse
base damage has not been fully established, but the three-dimensional
structure recently solved by x-ray crystallography brought about
suggestive insight into the substrate recognition and catalytic
mechanism of this enzyme (61, 62). Judging from available data (Refs.
43, 58, and 63 and this work), damage recognized by AlkA could be
roughly divided into two groups that are excised efficiently (3mA, 7mG,
fU, and O2-methylcytosine) and very poorly or
not at all (Hx,
A, hU, O2-methylthymine, and
O4-methylthymine). The excision efficiency of
the second group appears to be at least 2 or 3 orders of magnitude
lower than that of the first group. The positive charge in the base
moiety and concomitant destabilization of the N-glycosidic
bond were originally suggested as key features for the recognition by
AlkA (64). The half-lives of the N-glycosidic bond of
alkylated bases, fU and T (pH 7 and 37 °C, in free
deoxyribonucleosides) are 3mA (0.8 h) < 7mG (4.6 h) < O2ethylC (26 h) < fU (17 days) < O2ethylT (220 days) < O4ethylT ~ T (30, 65, 66), where bases bearing an
apparent positive charge at pH 7 are underlined (see also Fig.
8A), and the last two bases
(O4ethylT and T) are not substrates for AlkA (63). In
general, the damaged bases with a positive charge or a labile
N-glycosidic bond (3mA, 7mG, O2ethylC, and fU)
are good to fair substrates, although the order of the stability of the
N-glycosidic bond does not exactly correlate with the
excision efficiency by AlkA. For example, as shown in the present work,
7mG and fU are recognized with comparable efficiencies, yet their
half-lives of the N-glycosidic bond are significantly different. Therefore, these data imply that additional factors, either
steric or electronic, may also influence the base excision efficiency
of AlkA. It has been implicated by the structural and site-directed
mutagenesis data that the electron deficient bases flip out the DNA
duplex to form strong
-donor/acceptor interactions with
electron-rich aromatic amino acids present in the active site of AlkA
(62, 67). We suggest that a similar interaction is principally
operating in the recognition and/or excision of fU by AlkA. As shown by
the NMR data (Table III), the electron-withdrawing 5-formyl group in fU
causes the pyrimidine ring and deoxyribose C-1' electron deficient
relative to parent thymidine. The resonance structures of
5-formyl-2'-deoxyuridine are illustrated in Fig. 8B. As
presumed for the substrates bearing the apparent positive charge (3mA,
7mG, and O2ethylC), the delocalized positive charge through
the
electron system would increase the affinity of fU to the active
site composed of electron-rich aromatic rings and/or accelerate the
rupture of the N-glycosidic bond in the transition state. In
the latter case, the induced positive charge in deoxyribose C-1' will
promote the attack of a hydroxide ion on this atom, hence effecting the N-glycosylase reaction (62). In contrast, the 5-methyl and
5-hydroxymethyl groups in thymine and hU, respectively, are
intrinsically electron-donating groups and are therefore unable to
induce positive charges in the pyrimidine ring and deoxyribose C-1'.
Probably, this is the primary reason that hU and thymine are recognized
poorly or not at all.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
Structures and charges of base damage
differentially recognized by AlkA. A, structures and
charges at pH 7. B, resonance structures of
5-formyl-2'-deoxyuridine.
|
|
Although fU resulting from oxidation of thymine mostly pairs with
adenine, forming a correct base pair during DNA replication, it can
also form an fU:G mismatch with a certain frequency (29, 68).
Therefore, it is likely that cells need to deal with fU existing as two
different base pairs, i.e. fU:A and fU:G. The present study
has shown that fU in the fU:A pair is efficiently removed by AlkA, an
E. coli repair enzyme for alkylated bases. In the
accompanying paper (68), we report that fU present as an fU:G mispair
is recognized by two E. coli repair proteins, AlkA and MutS.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Kihei Kubo, Shuji Seki, Susumu
Nishimura, Zafer Hatahet, and Susan S. Wallace for generous gifts of
DNA repair enzymes and Drs. Zafri Humayun and Paul M. Dunman for
E. coli MV1161 and 1571. We are also grateful to Hironobu
Nakano and Takao Yamada for technical assistance and preparation of
oligonucleotides containing thymine glycol and Fapy.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid from Ministry of
Education, Science, Sports and Culture of Japan (to H. I.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel. & Fax:
+81-824-24-7457; E-mail: ideh@ipc.hiroshima-u.ac.jp.
2
Y. Yamagata, personal communication.
3
H. Terato, T. Yamada, K. Asagoshi, Y. Ohyama,
and H. Ide, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
fU, 5-formyluracil;
hU, 5-hydroxymethyluracil;
7mG, 7-methylguanine;
3mA, 3-methyladenine;
Hx, hypoxanthine;
A, 1,N6-ethenoadenine;
fdUTP, 5-formyl-2'-deoxyuridine 5'-triphosphate;
hdUTP, 5-hydroxymethyl-2'-deoxyuridine 5'-triphosphate;
Fapy, 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine;
MNNG, N-methyl-N'-nitro-N-nitrosoguanidine;
AlkA, E. coli 3-methyladenine DNA glycosylase II;
hMPG/Anpg, human methylpurine DNA glycosylase;
mNth1, mouse
endonuclease III homologue;
hOGG1/hMMH, human 7,8-dihydro-8-oxoguanine
DNA glycosylase/human MutM homologue;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel electrophoresis;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
HPLC, high
pressure liquid chromatography.
 |
REFERENCES |
| 1.
|
Friedberg, E. C.,
Walker, G. C.,
and Siede, W.
(1995)
DNA Repair and Mutagenesis
, AMS Press, Washington, D. C.
|
| 2.
|
Lindahl, T.
(1996)
Philos. Trans. R. Soc. Lond. B Biol. Sci.
351,
1529-1538[Medline]
[Order article via Infotrieve]
|
| 3.
|
von Sonntag, C.
(1987)
Chemical Basis of Radiation Biology
, Taylor & Francis, New York
|
| 4.
|
Breen, A. P.,
and Murphy, J. A.
(1995)
Free Radical Biol. Med.
18,
1033-1077[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Demple, B.,
and Harrison, L.
(1994)
Annu. Rev. Biochem.
63,
915-948[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Demple, B.,
and Linn, S.
(1980)
Nature
287,
203-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Katcher, H. L.,
and Wallace, S. S.
(1983)
Biochemistry
22,
4071-4081[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Breimer, L. H.,
and Lindahl, T.
(1984)
J. Biol. Chem.
259,
5543-5548[Abstract/Free Full Text]
|
| 9.
|
Didzaroglu, M.,
Laval, J.,
and Boiteux, S.
(1993)
Biochemistry
32,
12105-12111[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Melamede, R. J.,
Hatahet, Z.,
Kow, Y. W.,
Ide, H.,
and Wallace, S. S.
(1994)
Biochemistry
33,
1255-1264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Cunningham, R. P.,
and Weiss, B.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
474-478[Abstract/Free Full Text]
|
| 12.
|
Asahara, H.,
Wistort, P. M.,
Bank, J. F.,
Bakerian, R. H.,
and Cunningham, R. P.
(1989)
Biochemistry
28,
4444-4449[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Jiang, D.,
Hatahet, Z.,
Blaisdell, J. O.,
Melamede, R. J.,
and Wallace, S. S.
(1997)
J. Bacteriol.
179,
3773-3782[Abstract/Free Full Text]
|
| 14.
|
Saito, Y.,
Uraki, F.,
Nakajima, S.,
Asaeda, A.,
Ono, K.,
Kubo, K.,
and Yamamoto, K.
(1997)
J. Bacteriol.
179,
3773-3785
|
| 15.
|
Roldan-Arjona, T.,
Anselmino, C.,
and Lindahl, T.
(1996)
Nucleic Acids Res.
24,
3307-3312[Abstract/Free Full Text]
|
| 16.
|
Aspinwall, R.,
Rothwell, D. G.,
Roldan-Arjona, T.,
Anselmino, C.,
Ward, C. J.,
Cheadle, J. P.,
Sampson, J. R.,
Lindahl, T.,
Harris, P. C.,
and Hickson, I. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
109-114[Abstract/Free Full Text]
|
| 17.
|
Hilbert, T. P.,
Chaung, W.,
Boorstein, R. J.,
Cunningham, R. P.,
and Teebor, G. W.
(1997)
J. Biol. Chem.
272,
6733-6740[Abstract/Free Full Text]
|
| 18.
|
Sarker, A. H.,
Ikeda, S.,
Nakano, H.,
Terato, H.,
Ide, H.,
Imai, K.,
Akiyama, K.,
Tsutsui, K.,
Bo, Z.,
Kubo, K.,
Yamamoto, K.,
Yasui, A.,
Yoshida, M. C.,
and Seki, S.
(1998)
J. Mol. Biol.
273,
21585-21593
|
| 19.
|
Kow, Y. W.,
and Wallace, S. S.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
8354-8358[Abstract/Free Full Text]
|
| 20.
|
Wallace, S. S.
(1988)
Environ. Mol. Mutagen.
12,
431-477[Medline]
[Order article via Infotrieve]
|
| 21.
|
Purmal, A. A.,
Rabow, L. E.,
Lampman, G. W.,
Cunningham, R. P.,
and Kow, Y. W.
(1996)
Mutat. Res.
364,
193-207[Medline]
[Order article via Infotrieve]
|
| 22.
|
Breimer, L. H.,
and Lindahl, T.
(1980)
Nucleic Acids Res.
8,
6199-6211[Abstract/Free Full Text]
|
| 23.
|
Sanderson, B. J. S.,
Chang, C.-N.,
Grollman, A. P.,
and Henner, W. D.
(1989)
Biochemistry
28,
3894-3901[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Robson, C. N.,
Milne, A. M.,
Pappin, D. J.,
and Hickson, I. D.
(1991)
Nucleic Acids Res.
19,
1087-1092[Abstract/Free Full Text]
|
| 25.
|
Breimer, L. H.,
and Lindahl, T.
(1985)
Biochemistry
24,
4018-4022[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Hollstein, M. C.,
Brooks, P.,
Linn, S.,
and Ames, B.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4003-4007[Abstract/Free Full Text]
|
| 27.
|
Cannon-Carlson, S. V.,
Gokhale, H.,
and Teebor, G. W.
(1989)
J. Biol. Chem.
264,
13306-13312[Abstract/Free Full Text]
|
| 28.
|
Levy, D. D.,
and Teebor, G. W.
(1991)
Nucleic Acids Res.
19,
3337-3343[Abstract/Free Full Text]
|
| 29.
|
Yoshida, M.,
Makino, K.,
Morita, H.,
Terato, H.,
Ohyama, Y.,
and Ide, H.
(1997)
Nucleic Acids Res.
25,
1570-1577[Abstract/Free Full Text]
|
| 30.
|
Terato, H.,
Morita, H.,
Ohyama, Y.,
and Ide, H.
(1998)
Nucleosides Nucleotides
17,
131-141[Medline]
[Order article via Infotrieve]
|
| 31.
|
Kasai, H.,
Iida, A.,
Yamaizumi, Z.,
Nishimura, S.,
and Tanooka, H.
(1990)
Mutat. Res.
243,
249-253[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Bjelland, S.,
Eide, L.,
Time, R. W.,
Stote, R.,
Eftedal, I.,
Volden, G.,
and Seeberg, E.
(1995)
Biochemistry
34,
14758-14764[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bjelland, S.,
Birkeland, N.,
Benneche, T.,
Volden, G.,
and Seeberg, E.
(1994)
J. Biol. Chem.
269,
30489-30495[Abstract/Free Full Text]
|
| 34.
|
Zhang, Q.-M.,
Fujimoto, J.,
and Yonei, S.
(1995)
Int. J. Radiat. Biol.
68,
603-607[Medline]
[Order article via Infotrieve]
|
| 35.
|
Ono, A.,
Okamoto, T.,
Inada, M.,
Nara, H.,
and Matsuda, A.
(1994)
Chem. Pharm. Bull.
42,
2231-2237
|
| 36.
|
Wang, G.,
Palejwala, V. A.,
Dunman, P. M.,
Aviv, D. H.,
Murphy, H. S.,
Rahman, M. S.,
and Humayun, M. Z.
(1995)
Genetics
141,
813-823[Abstract]
|
| 37.
|
Volkert, M. R.,
Nguyen, D. C.,
and Beard, K. C.
(1986)
Genetics
112,
11-26[Abstract/Free Full Text]
|
| 38.
|
Asaeda, A.,
Ide, H.,
Tano, K.,
Takamori, Y.,
and Kubo, K.
(1998)
Nucleosides Nucleotides
17,
503-513[Medline]
[Order article via Infotrieve]
|
| 39.
|
Aburatani, H.,
Hippo, Y.,
Ishida, T.,
Takashima, R.,
Matsuba, C.,
Kodama, T.,
Takao, M.,
Yasui, A.,
Yamamoto, K.,
Asano, M.,
Fukasawa, K.,
Yoshinari, T.,
Inoue, H.,
Ohtsuka, E.,
and Nishimura, S.
(1997)
Cancer Res.
57,
2151-2156[Abstract/Free Full Text]
|
| 40.
|
Nakabeppu, Y.,
Miyata, T.,
Kondo, H.,
Iwanaga, S.,
and Sekiguchi, M.
(1984)
J. Biol. Chem.
259,
13730-13736[Abstract/Free Full Text]
|
| 41.
|
Ide, H.,
Okagami, M.,
Murayama, H.,
Kimura, Y.,
and Makino, K.
(1993)
Biochem. Mol. Biol. Int.
31,
485-491[Medline]
[Order article via Infotrieve]
|
| 42.
|
Kao, J. Y.,
Goljer, I.,
Phan, T. A.,
and Bolton, P. H.
(1993)
J. Biol. Chem.
268,
17787-17793[Abstract/Free Full Text]
|
| 43.
|
Saparbaev, M.,
and Laval, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5873-5877[Abstract/Free Full Text]
|
| 44.
|
O'Connor, T. R.,
and Laval, J.
(1990)
EMBO J.
9,
3337-3342[Medline]
[Order article via Infotrieve]
|
| 45.
|
Engelward, B. P.,
Boosalis, M. S.,
Chen, B. J.,
Deng, Z.,
Siciliano, M. J.,
and Samson, L. D.
(1993)
Carcinogenesis
14,
175-181[Abstract/Free Full Text]
|
| 46.
|
Chakravarti, D.,
Ibeanu, G. C.,
Tano, K.,
and Mitra, S.
(1991)
J. Biol. Chem.
266,
15710-15715[Abstract/Free Full Text]
|
| 47.
|
O'Connor, T.,
and Laval, J.
(1991)
Biochem. Biophys. Res. Commun.
176,
1170-1177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Samson, L. D.,
Derfler, B.,
Boosalis, M.,
and Call, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9127-9131[Abstract/Free Full Text]
|
| 49.
|
Rosenquist, T. A.,
Zharkov, D. O.,
and Grollman, A. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7429-7434[Abstract/Free Full Text]
|
| 50.
|
Radicella, J. P.,
Dherin, C.,
Desmaze, C.,
Fox, M. S.,
and Boiteux, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8010-8015[Abstract/Free Full Text]
|
| 51.
|
Roldan-Arjona, T.,
Wei, Y.-F.,
Carter, K. C.,
Klungland, A.,
Anselmino, C.,
Wang, R.-P.,
Augustus, M.,
and Lindahl, T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8016-8020[Abstract/Free Full Text]
|
| 52.
|
Arai, K.,
Morishita, K.,
Shinmura, K.,
Kohno, T.,
Kim, S.-R.,
Nohmi, T.,
Taniwaki, M.,
Ohwada, S.,
and Yokota, J.
(1997)
Oncogene
14,
2857-2861[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Thomas, L.,
Yang, C.-H.,
and Goldthwait, D. A.
(1982)
Biochem. J.
21,
1162-1169
|
| 54.
< |